News Column

Eleven Biotherapeutics to Report Second Quarter 2014 Financial Results on August 13, 2014

August 20, 2014

By a News Reporter-Staff News Editor at Biotech Week -- Eleven Biotherapeutics, Inc. (Nasdaq: EBIO), a clinical-stage biopharmaceutical company discovering and developing protein therapeutics to treat diseases of the eye, announced it will report second quarter 2014 financial results on Wednesday, August 13, 2014. Eleven's management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time on Wednesday, August 13, 2014 to discuss the quarterly results and recent business developments (see also Biopharmaceuticals).

To access the conference call, please dial (844) 831-3025 (domestic) or (315) 625-6887 (international) at least five minutes prior to the start time and refer to conference ID 82691260. An audio webcast of the call will also be available on the Investors & Media section of the company's website, An archived webcast will be available on the Company's website approximately two hours after the event and will be available for 30 days. About Eleven Biotherapeutics Eleven Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company with a proprietary protein engineering platform, called AMP-Rx, that it applies to the discovery and development of protein therapeutics to treat diseases of the eye. The Company's therapeutic approach is based on the role of cytokines in diseases of the eye, the Company's understanding of the structural biology of cytokines and the Company's ability to rationally design and engineer proteins to modulate the effects of cytokines. Cytokines are cell signaling molecules found in the body that can have important inflammatory effects.

Keywords for this news article include: Drugs, Cytokines, Biopharmaceuticals, Eleven Biotherapeutics Inc..

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Biotech Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters